Latest Morning Briefing Stories
En los comerciales de medicamentos en TV, lo que ves no siempre es lo que es
Los anuncios de medicamentos han sido omnipresentes en la televisión desde finales de la década de 1990 y se han extendido a internet y las redes sociales. Pocas naciones en el mundo los permiten
Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health
State leaders are cutting public health spending and laying off workers hired during a pandemic-era grant boom. Public health officials say the bust will erode important advancements in the public health safety net, particularly in rural areas.
Errors in Deloitte-Run Medicaid Systems Can Cost Millions and Take Years To Fix
As states wait for Deloitte to make fixes in computer systems, Medicaid beneficiaries risk losing access to health care and food.
Patients Suffer When Indian Health Service Doesn’t Pay for Outside Care
The Indian Health Service has a program that can pay for outside appointments when patients need care not offered at agency-funded sites. Critics say money shortages, complex rules, and administrative fumbles often block access, however.
Del auge a la caída: falta de dinero y despidos golpean a la salud pública
Ante la pandemia, el Congreso asignó más de $800 mil millones para fortalecer la respuesta de los estados ante covid. Esto resultó en un notable aumento del número de trabajadores de salud pública en todo el país. Ese dinero se ha esfumado.
Feds Killed Plan To Curb Medicare Advantage Overbilling After Industry Opposition
A private 2014 decision by the Centers for Medicare & Medicaid Services faces new scrutiny in a multibillion-dollar Justice Department fraud case against UnitedHealth Group.
An Arm and a Leg: Don’t Get ‘Bullied’ Into Paying What You Don’t Owe
In this episode of “An Arm and a Leg,” host Dan Weissmann speaks with Caitlyn Mai, a woman in Oklahoma who received a six-figure bill for a surgery her insurance promised to cover. This episode is an extended version of the “Bill of the Month” series, produced in partnership with NPR.
For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.
Para las farmacéuticas, la pelea entre Trump y Harris es entre dos enemigos de la industria
Legisladores de ambos partidos atacan cada vez más a la industria, por los precios de los medicamentos que la mayoría de los estadounidenses consideran irrazonables.
Biden Administration Blocks Two Private Sector Enrollment Sites From ACA Marketplace
Regulators have been under the gun to curb unauthorized Obamacare enrollment and switching of plans. Separately, a pending lawsuit was amended with additional defendants and new allegations regarding tactics to garner greater ACA sales commissions.